Diality Stock

Diality is a medical device company developing solutions that improve lives impacted by kidney disease.

Sign up today and learn more about Diality Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Diality Stock

Diality is developing a patient-inspired hemodialysis solution to improve lives impacted by kidney disease. Our solution is versatile, simple, and fully powered. Integrated dialysate production coupled with high maximum dialysate and blood flow rates allow physicians to prescribe the best treatment for each patient, regardless of care setting and without compromise.* *This product is not yet available for use in the EU or US and is pending CE Mark and submission and clearance by the United States Food and Drug Administration. Performance claims referenced are development goals.

Funding History

June 2018$8.0M
June 2019$10.0M
October 2020$12.5M
March 2022$24.0M
August 2023$28.0M



Osman Khawar

Chief Scientific Officer and Vice President of Medical Affairs

Timothy McNamara


Clayton D. Poppe

Non Executive Director

Martin Riediker


Ronald Strässler

Non Executive Director

Martin Pasek


Pamela Wapnick

Co-Founder & Board Member

Aaron Mishkin


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: